MM 111 - Elevation Oncology
Q3 '12 Results (Merrimack) - Nov 15, 2012 - Anticipated initiation of P2 trial for second line gastric cancer by November 2013 
Anticipated new P2 trial Breast Cancer
http://www.larvolonline.com/tlg/ccdb/MerrimackPharmaQ3'12ResultsNov142012.pdf
 
Nov 15, 2012
 
MM 111 --- Merrimack anticipates the following milestones in the next 12 months: Initiation of a Phase 2 clinical trial for MM-111 in second line gastric cancer; ---